Subject: ONCX Reaches Another Crucial Milestone Begins Second Dosing in Phase 1 Clinical Trials
ONCX Reaches Another Crucial Milestone Begins Second Dosing in Phase 1 Clinical Trials
January 8th, 2018 at 11:16 am EDTBY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information ...
RXMD is 5 Star Pharmacy with a Unique Approach Driving Revenues and Shareholder Value Up
January 8th, 2018 at 10:38 am EDTBY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information ...
CEO Letter Outlines 2017 Results and Spotlights 2018 Goals
January 3rd, 2018 at 10:30 am EDTBY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information ...
The Market Responds Positively to Recent TRTC News About Adult Use Cannabis Sales in California Kicking Off
January 2nd, 2018 at 10:54 am EDTBY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information ...